Correlation Between Kunwu Jiuding and Suzhou Novoprotein

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kunwu Jiuding and Suzhou Novoprotein at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kunwu Jiuding and Suzhou Novoprotein into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kunwu Jiuding Investment and Suzhou Novoprotein Scientific, you can compare the effects of market volatilities on Kunwu Jiuding and Suzhou Novoprotein and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kunwu Jiuding with a short position of Suzhou Novoprotein. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kunwu Jiuding and Suzhou Novoprotein.

Diversification Opportunities for Kunwu Jiuding and Suzhou Novoprotein

0.93
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Kunwu and Suzhou is 0.93. Overlapping area represents the amount of risk that can be diversified away by holding Kunwu Jiuding Investment and Suzhou Novoprotein Scientific in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Suzhou Novoprotein and Kunwu Jiuding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kunwu Jiuding Investment are associated (or correlated) with Suzhou Novoprotein. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Suzhou Novoprotein has no effect on the direction of Kunwu Jiuding i.e., Kunwu Jiuding and Suzhou Novoprotein go up and down completely randomly.

Pair Corralation between Kunwu Jiuding and Suzhou Novoprotein

Assuming the 90 days trading horizon Kunwu Jiuding Investment is expected to generate 1.38 times more return on investment than Suzhou Novoprotein. However, Kunwu Jiuding is 1.38 times more volatile than Suzhou Novoprotein Scientific. It trades about 0.16 of its potential returns per unit of risk. Suzhou Novoprotein Scientific is currently generating about 0.13 per unit of risk. If you would invest  1,164  in Kunwu Jiuding Investment on September 4, 2024 and sell it today you would earn a total of  501.00  from holding Kunwu Jiuding Investment or generate 43.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Kunwu Jiuding Investment  vs.  Suzhou Novoprotein Scientific

 Performance 
       Timeline  
Kunwu Jiuding Investment 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Kunwu Jiuding Investment are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Kunwu Jiuding sustained solid returns over the last few months and may actually be approaching a breakup point.
Suzhou Novoprotein 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Suzhou Novoprotein Scientific are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Suzhou Novoprotein sustained solid returns over the last few months and may actually be approaching a breakup point.

Kunwu Jiuding and Suzhou Novoprotein Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kunwu Jiuding and Suzhou Novoprotein

The main advantage of trading using opposite Kunwu Jiuding and Suzhou Novoprotein positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kunwu Jiuding position performs unexpectedly, Suzhou Novoprotein can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Suzhou Novoprotein will offset losses from the drop in Suzhou Novoprotein's long position.
The idea behind Kunwu Jiuding Investment and Suzhou Novoprotein Scientific pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance